Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
4
×
clinical trials
life sciences
4
×
national blog main
san francisco blog main
cancer drugs
national top stories
san francisco top stories
ipo
revolution medicines
roche
san francisco
sanofi
the column group
third rock ventures
warp drive bio
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
amgen
aprea therapeutics
arimoclomol
arnold levine
baker brothers
biotech ipos
black diamond therapeutics
bladder cancer
blueprint medicines
boehringer ingelheim
cancer diagnostics
cdg therapeutics
cirina
cobimetinib
colorectal cancer
daiichi sankyo
deals
What
cancer
4
×
ipo
4
×
medicines
research
drug
proteins
revolution
targets
biotech
black
blood
broader
cancer’s
clinic
companies
company
despite
detect
developing
diamond
disease
eluded
family
files
firms
frontiers
grail
hardest
hit
hopes
hottest
hunters
intended
investors
join
known
lead
leading
life
lines
Language
unset
Current search:
cancer
×
" life sciences "
×
cancer
×
ipo
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic